Metabolic correction of experimental diabetic retinopathy
Introduction. Diabetic retinopathy (DR) is diagnosed in 50% of the total number of patients suffering from type 1 diabetes mellitus with diabetes duration of over 10 years and in 75-90% of patients with diabetes duration over 15 years. Purpose. To ground the possibility of using arginine for corr...
Main Authors: | I.V. Savitskyi, V.V. Semenko, V.M. Serdiuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Ukrainian Society of Ophthalmologists
2017-12-01
|
Series: | Journal of Ophthalmology |
Subjects: | |
Online Access: | https://www.ozhurnal.com/en/archive/2017/6/12-fulltext |
Similar Items
-
Results of histological examination of experimental diabetic retinopathy and its correction with metformin, aflibercept, L-arginine solution and cyticolin
by: Y. Sirman, et al.
Published: (2020-12-01) -
Awareness of Diabetic Retinopathy among Patients with Diabetes Mellitus in Ilorin, Nigeria
by: Olokoba L. B., et al.
Published: (2017-07-01) -
Histological analysis of the eyeball of Neotropical birds of prey Caracara plancus, Falco sparverius, Rupornis magnirostris, Megascops choliba and Athene cunicularia
by: Débora Galdino Pinto, et al.
Published: (2016-10-01) -
Diabetic retinopathy
by: A Kittantong
Published: (2006-04-01) -
Awareness, knowledge, and practices related to diabetic retinopathy among diabetic patients in primary healthcare centers at Riyadh, Saudi Arabia
by: Manal H AlHargan, et al.
Published: (2019-01-01)